Yue Xu1, Ming Zheng2, Robert E Merritt1, Joseph B Shrager3, Heather A Wakelee4, Robert A Kratzke5, Chuong D Hoang6. 1. Division of Thoracic Surgery, Department of Medicine, Stanford University School of Medicine, Stanford, CA. 2. Department of Cardiothoracic Surgery, Department of Anesthesia, Department of Medicine, Stanford University School of Medicine, Stanford, CA. 3. Division of Thoracic Surgery, Department of Medicine, Stanford University School of Medicine, Stanford, CA; Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA. 4. Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA. 5. Division of Hematology, Oncology, and Transplant, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN. 6. Division of Thoracic Surgery, Department of Medicine, Stanford University School of Medicine, Stanford, CA; Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA. Electronic address: cdhoang@stanford.edu.
Abstract
BACKGROUND: We investigated microRNA expression profiles of malignant pleural mesothelioma (MPM) specimens to identify novel microRNA that are potentially involved in the oncogenic transformation of human pleural cells. METHODS: microRNA microarray transcriptional profiling studies of 25 MPM primary tumors were performed. We used normal pleural tissue from an unmatched patient cohort as normal comparators. To confirm microarray data, we used real-time quantitative polymerase chain reaction. Representative cell lines H513 and H2052 were used in functional analyses of miR-1. RESULTS: In addition to several novel MPM-associated microRNAs, we observed that the expression level of miR-1 was significantly lower in tumors as compared with normal pleural specimens. Subsequently, pre-miR of miR-1 was introduced into MPM cell lines to overexpress this microRNA. Phenotypic changes of these altered cells were assayed. The cellular proliferation rate was significantly inhibited after overexpression of miR-1. Early and late apoptosis was increased markedly in miR-1-transfected cell lines. Taken together, these data suggested that overexpression of miR-1 induced apoptosis in these MPM cell lines, acting as a tumor suppressor. We confirmed our observations by assessing in the transduced MPM cells cell cycle-related, proapoptotic, and antiapoptotic genes, which all showed coordinated, significant changes characteristic of the apoptotic phenotype. CONCLUSIONS: Further investigation and validation of our microRNA database of MPM may elucidate previously unrecognized molecular pathways and/or mechanisms by identifying novel microRNAs that are involved in malignant transformation. Our study has now found miR-1 to be one of these MPM-associated microRNAs, with potential pathogenic and therapeutic significance.
BACKGROUND: We investigated microRNA expression profiles of malignant pleural mesothelioma (MPM) specimens to identify novel microRNA that are potentially involved in the oncogenic transformation of human pleural cells. METHODS: microRNA microarray transcriptional profiling studies of 25 MPM primary tumors were performed. We used normal pleural tissue from an unmatched patient cohort as normal comparators. To confirm microarray data, we used real-time quantitative polymerase chain reaction. Representative cell lines H513 and H2052 were used in functional analyses of miR-1. RESULTS: In addition to several novel MPM-associated microRNAs, we observed that the expression level of miR-1 was significantly lower in tumors as compared with normal pleural specimens. Subsequently, pre-miR of miR-1 was introduced into MPM cell lines to overexpress this microRNA. Phenotypic changes of these altered cells were assayed. The cellular proliferation rate was significantly inhibited after overexpression of miR-1. Early and late apoptosis was increased markedly in miR-1-transfected cell lines. Taken together, these data suggested that overexpression of miR-1 induced apoptosis in these MPM cell lines, acting as a tumor suppressor. We confirmed our observations by assessing in the transduced MPM cells cell cycle-related, proapoptotic, and antiapoptotic genes, which all showed coordinated, significant changes characteristic of the apoptotic phenotype. CONCLUSIONS: Further investigation and validation of our microRNA database of MPM may elucidate previously unrecognized molecular pathways and/or mechanisms by identifying novel microRNAs that are involved in malignant transformation. Our study has now found miR-1 to be one of these MPM-associated microRNAs, with potential pathogenic and therapeutic significance.
Authors: Ashfaq M Sheikh; Mazhar Malik; Guang Wen; Abha Chauhan; Ved Chauhan; Cheng-Xin Gong; Fei Liu; William T Brown; Xiaohong Li Journal: J Neurosci Res Date: 2010-09 Impact factor: 4.164
Authors: Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang Journal: J Cell Physiol Date: 2012-01 Impact factor: 6.384
Authors: Stefano Volinia; Marco Galasso; Stefan Costinean; Luca Tagliavini; Giacomo Gamberoni; Alessandra Drusco; Jlenia Marchesini; Nicoletta Mascellani; Maria Elena Sana; Ramzey Abu Jarour; Caroline Desponts; Michael Teitell; Raffaele Baffa; Rami Aqeilan; Marilena V Iorio; Cristian Taccioli; Ramiro Garzon; Gianpiero Di Leva; Muller Fabbri; Marco Catozzi; Maurizio Previati; Stefan Ambs; Tiziana Palumbo; Michela Garofalo; Angelo Veronese; Arianna Bottoni; Pierluigi Gasparini; Curtis C Harris; Rosa Visone; Yuri Pekarsky; Albert de la Chapelle; Mark Bloomston; Mary Dillhoff; Laura Z Rassenti; Thomas J Kipps; Kay Huebner; Flavia Pichiorri; Dido Lenze; Stefano Cairo; Marie-Annick Buendia; Pascal Pineau; Anne Dejean; Nicola Zanesi; Simona Rossi; George A Calin; Chang-Gong Liu; Jeff Palatini; Massimo Negrini; Andrea Vecchione; Anne Rosenberg; Carlo M Croce Journal: Genome Res Date: 2010-05 Impact factor: 9.043
Authors: Gretchen V Gee; Devin C Koestler; Brock C Christensen; David J Sugarbaker; Donatella Ugolini; Giovanni P Ivaldi; Murray B Resnick; E Andres Houseman; Karl T Kelsey; Carmen J Marsit Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396
Authors: Patrícia M Pereira; João Paulo Marques; Ana R Soares; Laura Carreto; Manuel A S Santos Journal: PLoS One Date: 2010-07-26 Impact factor: 3.240
Authors: H E Gee; F M Buffa; C Camps; A Ramachandran; R Leek; M Taylor; M Patil; H Sheldon; G Betts; J Homer; C West; J Ragoussis; A L Harris Journal: Br J Cancer Date: 2011-03-15 Impact factor: 7.640
Authors: A Truini; S Coco; A Alama; C Genova; C Sini; M G Dal Bello; G Barletta; E Rijavec; G Burrafato; F Boccardo; F Grossi Journal: Cell Mol Life Sci Date: 2014-02-23 Impact factor: 9.261